U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038941) titled 'Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia' on June 17.
Brief Summary: This study is testing CG2001, a new medicine that is applied as a light foam to the scalp and is being developed to treat male-pattern hair loss (androgenetic alopecia). The main goals are to find out:
1. Whether single and repeated daily doses of CG2001 are safe and well-tolerated
2. How much of the drug, if any, enters the bloodstream (pharmacokinetics)
Study Start Date: March 19, 2024
Study Type: INTERVENTIONAL
Condition:
Male Pattern of Hair Loss, Androgenic Alopecia
Androgenetic Alopecia (AGA)
Interv...